Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Dare Bioscience Inc DARE

Healthcare Biotechnology
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation... see more

Current News (NDAQ:DARE)

Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth

GlobeNewswire 34 minutes ago

Daré Bioscience Participates in Virtual Investor "What This Means" Segment

GlobeNewswire 4 days ago

Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

GlobeNewswire February 23, 2026

Telehealth Now Available for DARE to PLAY(TM) Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women

GlobeNewswire February 11, 2026

DARE to PLAY(TM) Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility

GlobeNewswire December 10, 2025

Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization

GlobeNewswire December 1, 2025

Daré Bioscience Receives $3.6 Million in Additional Grant Funding

GlobeNewswire November 24, 2025

Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire November 13, 2025

Daré Bioscience Highlights Commercial Launch Readiness for DARE to PLAY(TM) Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women's Sexual Health

GlobeNewswire November 11, 2025
View More News ››

Opinion & Analysis (NDAQ:DARE)

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Streetwise Reports May 21, 2020

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Streetwise Reports January 16, 2020

Biopharma 'Keeps Executing and Securing Milestones'

Streetwise Reports December 19, 2019

Biotech Firm ''Creating Innovative Solutions' for Female Health

Streetwise Reports July 24, 2019

Biotech Announces Preclinical Data on its Intravaginal Rings at Meeting

Streetwise Reports November 13, 2018

Biopharma's Positive FDA Meeting Outlines Path Forward for Trial

Streetwise Reports September 12, 2018
View More Opinion ››

Bullboard Posts (NDAQ:DARE)

Using technical analysis for this stock.

It is signalling a continuing uptrend for shareholders this morning anyway
coolfooldumbguy - July 15, 2025

Buy buddy buy because it's taking off this morning.

Otherwise you guys out there will be missing out on this stock today or FOMO  anyway
coolfooldumbguy - July 14, 2025

Dare Bioscience, Inc.: Advancing Innovative Women’s He

http://beyondspx.com/2024/08/02/dare-bioscience-inc-advancing-innovative-womens-health-solutions-with-a-robust-pipeline-and-strategic...
MikeTester - August 3, 2024

War

<< View Post To Watch Video >>
StandTall - April 19, 2022

DARE - Will Increase In Price Next Week

<< View Post To Watch Video >>
HDavis - December 12, 2021

Chefboy69.....Stock Board Poser?

Since Chefboy69 felt it necessary to pop into the HUGE board and talk shite and throw around personal insults out of the blue, I thought...
Mil_Man54 - December 4, 2021
View more Bullboard ››

Sekur Private Data Ltd.

Sekur Private Data Ltd.

Sekur Private Data Ltd. operates as a cybersecurity and internet privacy provider of Swiss hosted solutions for secure ...
View More »

Podcasts